Подписаться
Jean-Luc Teillaud
Jean-Luc Teillaud
Directeur de recherche Inserm
Подтвержден адрес электронной почты в домене inserm.fr
Название
Процитировано
Процитировано
Год
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer
C Germain, S Gnjatic, F Tamzalit, S Knockaert, R Remark, J Goc, ...
American journal of respiratory and critical care medicine 189 (7), 832-844, 2014
6642014
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
M Debré, C Griscelli, MC Bonnet, E Carosella, N Philippe, P Reinert, ...
The Lancet 342 (8877), 945-949, 1993
3951993
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects
M Allez, K Karmiris, E Louis, G Van Assche, S Ben-Horin, A Klein, ...
Journal of Crohn's and Colitis 4 (4), 355-366, 2010
3712010
Highly resolved chemical imaging of living cells by using synchrotron infrared microspectrometry
N Jamin, P Dumas, J Moncuit, WH Fridman, JL Teillaud, GL Carr, ...
Proceedings of the National Academy of Sciences 95 (9), 4837-4840, 1998
3211998
Differential modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by Th1 and Th2 cytokines
L Pricop, P Redecha, JL Teillaud, J Frey, WH Fridman, C Sautes-Fridman, ...
The Journal of Immunology 166 (1), 531-537, 2001
3032001
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
R Abès, E Gélizé, WH Fridman, JL Teillaud
Blood, The Journal of the American Society of Hematology 116 (6), 926-934, 2010
2362010
Regulated expression and inhibitory function of FcγRIIb in human monocytic cells
S Tridandapani, K Siefker, JE Carter, MD Wewers, CL Anderson, ...
Journal of Biological Chemistry 277 (7), 5082-5089, 2002
1972002
p53 antibodies in patients with various types of cancer: assay, identification, and characterization.
R Lubin, B Schlichtholz, JL Teillaud, E Garay, A Bussel, CP Wild
Clinical cancer research: an official journal of the American Association …, 1995
1821995
Structural bases of Fcγ receptor functions
WH Fridman, C Bonnerot, M Daeron, S Amigorena, JL Teillaud, C Sautes
Immunological reviews 125 (1), 49-76, 1992
1771992
Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression
O Cochet, M Kenigsberg, I Delumeau, A Virone-Oddos, MC Multon, ...
Cancer research 58 (6), 1170-1176, 1998
1761998
Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques
C Moog, N Dereuddre-Bosquet, JL Teillaud, ME Biedma, V Holl, ...
Mucosal immunology 7 (1), 46-56, 2014
1742014
Impact of glycosylation on effector functions of therapeutic IgG
R Abès, JL Teillaud
Pharmaceuticals 3 (1), 146-157, 2010
1642010
CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells
AR Mantegazza, MM Barrio, S Moutel, L Bover, M Weck, P Brossart, ...
Blood 104 (4), 1183-1190, 2004
1512004
Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels.
S Amigorena, D Choquet, JL Teillaud, H Korn, WH Fridman
Journal of immunology (Baltimore, Md.: 1950) 144 (6), 2038-2045, 1990
1481990
Chronic lymphocytic leukaemia cells are efficiently killed by an anti‐CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16
C De Romeuf, CA Dutertre, M Le Garff‐Tavernier, N Fournier, C Gaucher, ...
British Journal of Haematology 140 (6), 635-643, 2008
1462008
Molecular aspects of human FcγR interactions with IgG: functional and therapeutic consequences
S Sibéril, CA Dutertre, C Boix, E Bonnin, R Ménez, E Stura, S Jorieux, ...
Immunology letters 106 (2), 111-118, 2006
1362006
FcγR: the key to optimize therapeutic antibodies?
S Siberil, CA Dutertre, WH Fridman, JL Teillaud
Critical reviews in oncology/hematology 62 (1), 26-33, 2007
1282007
Chemical heterogeneity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells
N Jamin, L Miller, J Moncuit, WH Fridman, P Dumas, JL Teillaud
Biopolymers: Original Research on Biomolecules 72 (5), 366-373, 2003
1262003
FcγRII expression in resting and activated B lymphocytes
S Amigorena, C Bonnerot, D Choquet, WH Fridman, JL Teillaud
European journal of immunology 19 (8), 1379-1385, 1989
1191989
Selection of a human anti-RhD monoclonal antibody for therapeutic use: Impact of IgG glycosylation on activating and inhibitory FcγR functions
S Sibéril, C de Romeuf, N Bihoreau, N Fernandez, JL Meterreau, ...
Clinical Immunology 118 (2-3), 170-179, 2006
1162006
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20